PEN Q1 2025 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena

PENPenumbra, Inc.

$13B

Q1 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$324M+16.3% YoY

Gross Profit

$216M66.6% margin

Operating Income

$40M12.4% margin

Net Income

$39M12.1% margin

EPS (Diluted)

$1.00

QoQ Revenue Growth

+2.7%

Cash Flow

Operating Cash Flow

$49M

Free Cash Flow

$36M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$380M

Stockholders' Equity

$1.2B

Cash & Equivalents

$376M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$324M	$279M	+16.3%
Gross Profit	$216M	$181M	+19.2%
Operating Income	$40M	$12M	+233.4%
Net Income	$39M	$11M	+256.5%

Geographic Segments

UNITED STATES

$257M79%

Other Non-US

$67M21%